← К результатам

Biomed Pharmacother · 2021

CRISPR technology: The engine that drives cancer therapy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 133: 111007 PMID 33227699 DOI 10.1016/j.biopha.2020.111007

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

CRISPR gene editing technology belongs to the third generation of gene editing technology. Since its discovery, it has attracted the attention of a large number of researchers. Investigators have published a series of academic articles and obtained breakthrough research results through in-depth research. In recent years, this technology has developed rapidly and been widely applied in many fields, especially in medicine. This review focuses on concepts of CRISPR gene editing technology, its application in cancer treatments, its existing limitations, and the new progress in recent years for detailed analysis and sharing.

Цитирование